RNF5 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, RNF5 KD in the K562 (CML) line did not sensitize cells to FK228, and RNF5 KD in Jurkat cells (T-ALL) only slightly enhanced cell sensitivity to FK228 (Supplementary Fig. 7j and k).